Regression analyses indicated that exercise implemented before (ES = −0.17) or during cancer treatment (ES = −0.23) showed more negative VEGF estimates, whereas post-treatment survivors demonstrated a response pattern more consistent with healthy individuals (ES = 0.14). This evidence concerns the gene VEGFA and cancer.